About Behold.ai
Behold.ai is a Healthcare company based in New York (United States) founded in 2015. AI-powered diagnostic solutions are provided for radiology imaging. It operates on a AI-as-a-Service model. Behold.ai has raised $100 thousand across 1 funding round from investors including Gener8tor. The company has 11 employees. The company has since been acquired. Behold.ai offers products and services including red dot® Lung Cancer Detection Platform and red dot® CTH V1. Its focus areas include Medical Technology and AI Diagnostics. Its legal entity is Behold.ai Global Technologies Limited. Its competitors include Change Healthcare, AIdoc and Viz.ai; 3 of its 3 listed competitors have raised funding.
Company details
AI-driven diagnostic platforms are developed by Behold.ai for radiology imaging, focusing on rapid detection of critical conditions like lung cancer and stroke. Solutions are offered to healthcare providers globally, with products such as red dot Lung Cancer Detection Platform and red dot CTH V1. Significant reductions in diagnostic backlogs are achieved, as demonstrated in NHS trusts and hospitals in the UK, USA, and India. Clinical validation is ensured through extensive patient analysis and regulatory approvals from FDA and CE.
- Total Equity Funding$100K (USD)
in 1 rounds
- Latest Funding Round$100K (USD), Seed
Feb 2016
- InvestorsGener8tor
& 1 more
- Employee Count11
Products & Services of Behold.ai
Behold.ai offers a comprehensive portfolio of products and services, including red dot® Lung Cancer Detection Platform and red dot® CTH V1.
Lung cancer cases are triaged for faster decisions.
CT head exams are triaged for urgent care.
Funding Insights of Behold.ai
Behold.ai has successfully raised a total of $100K through 1 strategic funding round. The most recent funding activity was a Seed round of $100 thousand completed in February 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $100,000
- Total Rounds 1
- Last Round Seed — $100,000
- First Round $100,000
(Feb 2016)
- Investors Count 1
All 1 funding rounds of Behold.ai with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2016 | $100,000 | Seed | – | Gener8tor | – |
1 investors in total: 1 institutional.
Investors in Behold.ai
Behold.ai has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Gener8tor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Startups are accelerated via a 12-week program with funding support. | 2012 | gener8tor.com | Madison, United States |
Investor details for Behold.ai
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Behold.ai
9 people are tracked at Behold.ai (1 in leadership, 8 in team); the tracked headcount is 11.
| Name | Role | Group |
|---|---|---|
Thomas Naunton Morgan | Chief Medical Officer | Leadership |
Indy Nandra | Quality Assurance & Compliance Officer | Team |
Jordan Smith | Technical Product Manager | Team |
Rakesh Mehan | Consultant Radiologist | Team |
Michael Hughes | Consultant Radiologist | Team |
Teik Chooi Oh | Consultant Radiologist | Team |
Sanjiv Chawda | CT Lead | Team |
Jim Gray | Consultant Orthopaedic Surgeon | Team |
Sherif Raouf | Consultant Clinical Oncologist | Team |
Complete people profiles for Behold.ai
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Behold.ai
2 dated milestones of Behold.ai across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Behold.ai is founded.
- Funding First funding round of $100K.
Competitors of Behold.ai
Behold.ai has 3 listed competitors in our database, 3 of them funded. They include Change Healthcare, AIdoc and Viz.ai.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| changehealthcare.com | 2007 | Nashville, United States | $35.99M | 11,310 | Cloud-based solutions are delivered for healthcare payers, providers, and patients. | |
| aidoc.com | 2016 | New York, United States | $424.5M | AI-based single-screen system is provided to streamline medical imaging. | ||
| viz.ai | 2016 | San Francisco, United States | $251.99M | 206 | AI and cloud-powered software for stroke care coordination is developed. |
Detailed competitors of Behold.ai
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Behold.ai
The website of Behold.ai (behold.ai) receives about 3.1K visits a month.
- Monthly visits3.1K
▲ 770.2% vs previous month
Websites whose visitors overlap most with Behold.ai. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
annalise.ai | annalise.ai | 100% | – | ||
| xrayinterpreter.com | 87% | 102.8K | #322,884 | View details |
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Behold.ai (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Behold.Ai
Complete news archive for Behold.ai
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Behold.ai
Behold.ai was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Behold.ai is headquartered in New York, United States. It is registered at New York, New York, United States.
Behold.ai is a funded company, having raised a total of $100K across 1 funding round to date. The company's 1st funding round was a Seed of $100K, raised on Feb 2016.
Behold.ai has 11 employees.
AI-driven diagnostic platforms are developed by Behold.ai for radiology imaging, focusing on rapid detection of critical conditions like lung cancer and stroke. Solutions are offered to healthcare providers globally, with products such as red dot Lung Cancer Detection Platform and red dot CTH V1. Significant reductions in diagnostic backlogs are achieved, as demonstrated in NHS trusts and hospitals in the UK, USA, and India. Clinical validation is ensured through extensive patient analysis and regulatory approvals from FDA and CE.
Behold.ai's top competitors include Change Healthcare, AIdoc and Viz.ai.
Behold.ai offers red dot® Lung Cancer Detection Platform and red dot® CTH V1.
Behold.ai has 1 investor. Key investors include Gener8tor.
Behold.ai operates through Behold.Ai Global Technologies Limited.